Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab?
Ann Transl Med
.
2018 Nov;6(Suppl 1):S62.
doi: 10.21037/atm.2018.10.35.
Authors
Kate Smith-Jackson
1
,
Kevin J Marchbank
1
Affiliation
1
NRCTC and Newcastle University, The medical school, Farmington place, Newcastle-upon-Tyne, UK.
PMID:
30613637
PMCID:
PMC6291531
DOI:
10.21037/atm.2018.10.35
No abstract available
Publication types
Editorial
Comment
Grants and funding
MR/R001359/1/MRC_/Medical Research Council/United Kingdom